Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/87104
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sullivan, S. | - |
dc.contributor.author | Chilver, M. | - |
dc.contributor.author | Higgins, G. | - |
dc.contributor.author | Cheng, A. | - |
dc.contributor.author | Stocks, N. | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | Medical Journal of Australia, 2014; 201(2):109-111 | - |
dc.identifier.issn | 0025-729X | - |
dc.identifier.issn | 1326-5377 | - |
dc.identifier.uri | http://hdl.handle.net/2440/87104 | - |
dc.description.abstract | OBJECTIVE: To estimate influenza vaccine coverage and effectiveness against medically attended laboratory-confirmed influenza for the 2012 season. DESIGN, SETTING AND PARTICIPANTS: Test-negative design involving patients recruited as part of the Australian Sentinel Practices Research Network, a network of sentinel general practitioners throughout Australia. Throughout 2012, at the discretion of the GP at one of 102 participating practices, patients presenting with influenza-like illness were swabbed and included in the study. MAIN OUTCOME MEASURE: Influenza vaccine effectiveness (VE) estimated as (1-OR)*100% by logistic regression. RESULTS: 1775 patients were swabbed. The epidemic period was identified as Weeks 10 to 43 of 2012. After exclusions, there were 1414 patients for the VE analysis, including 593 (42%) who tested influenza-positive and 821 who tested negative. 27% of test-negative patients were vaccinated, of whom most were aged 50 years and over. The overall VE, adjusted for age group, month of presentation and state or territory, was 23% (95% CI, -4% to 43%) against all influenza types, 15% (95% CI, -17% to 38%) against influenza A, 13% (95% CI, -20% to 36%) against influenza A(not H1) and 53% (95% CI, 5% to 77%) against influenza B. CONCLUSION: Vaccination against influenza was modestly protective, reducing the risk of medical presentation with influenza by around 23%. | - |
dc.description.statementofresponsibility | Sheena G Sullivan, Monique B-N Chilver, Geoff Higgins, Allen C Cheng, Nigel P Stocks | - |
dc.language.iso | en | - |
dc.publisher | MJA Group Australia | - |
dc.rights | Copyright status unknown | - |
dc.source.uri | http://dx.doi.org/10.5694/mja14.00106 | - |
dc.subject | Humans | - |
dc.subject | Influenza Vaccines | - |
dc.subject | Vaccination | - |
dc.subject | Sentinel Surveillance | - |
dc.subject | Logistic Models | - |
dc.subject | Adolescent | - |
dc.subject | Adult | - |
dc.subject | Aged | - |
dc.subject | Aged, 80 and over | - |
dc.subject | Middle Aged | - |
dc.subject | Child | - |
dc.subject | Child, Preschool | - |
dc.subject | Infant | - |
dc.subject | Australia | - |
dc.subject | Female | - |
dc.subject | Male | - |
dc.subject | Influenza, Human | - |
dc.subject | Young Adult | - |
dc.subject | General Practice | - |
dc.title | Influenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.5694/mja14.00106 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Sullivan, S. [0000-0002-0856-0294] | - |
dc.identifier.orcid | Chilver, M. [0000-0001-6369-8483] | - |
dc.identifier.orcid | Stocks, N. [0000-0002-9018-0361] | - |
Appears in Collections: | Aurora harvest 2 General Practice publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.